Anti-Mouse CD309 (FLK1) PE 50 ug
- Known as:
- Antibody toMouse CD309 (FLK1) PE 50 ug
- Catalog number:
- 12-5821-81
- Category:
- -
- Supplier:
- eBioscience
- Gene target:
- Anti-Mouse CD309 (FLK1) 50
Related genes to: Anti-Mouse CD309 (FLK1) PE 50 ug
- Gene:
- KDR NIH gene
- Name:
- kinase insert domain receptor
- Previous symbol:
- -
- Synonyms:
- FLK1, VEGFR, VEGFR2, CD309
- Chromosome:
- 4q12
- Locus Type:
- gene with protein product
- Date approved:
- 1991-07-10
- Date modifiied:
- 2019-04-23
Related products to: Anti-Mouse CD309 (FLK1) PE 50 ug
Related articles to: Anti-Mouse CD309 (FLK1) PE 50 ug
- Alzheimer's disease (AD) is a neurodegenerative disorder with a global prevalence, currently lacking effective treatments and posing a major public health challenge due to the burden it places on healthcare systems while affecting millions of people. Melatonin is a hormone with considerable potential for treating various neurodegenerative disorders, including AD. The mechanisms responsible for melatonin's therapeutic benefits in Alzheimer's disease (AD) require further elucidation. This study was designed to investigate the mechanisms by which melatonin exerts its effects in APP/PS1 mice. - Source: PubMed
Publication date: 2026/08/17
Li XuepeiChen ZejunGuan JunwenYu HangWang Junjie - Nucleoside analogues are traditionally developed as antimetabolites that interfere with nucleic acid synthesis after intracellular phosphorylation. In this study, inspired by the 3',4'-unsaturated sugar scaffold of ddhCTP, we designed and synthesized a series of 3',4'-unsaturated nucleoside analogues to explore their antiproliferative potential and possible non-classical cellular effects. Among the synthesized compounds, 17k, a C-nucleoside bearing both a 3',4'-unsaturated sugar moiety and a chlorinated remdesivir-like base, exhibited potent antiproliferative activity against HepG2 cells, with an IC₅₀ value of 2.27 ± 0.36 μM, lower than that of gemcitabine under the same assay conditions. In the nonmalignant GES-1 epithelial cell line, 17k showed an IC₅₀ value of 34.26 ± 3.45 μM, corresponding to a selectivity index of 15.1 relative to HepG2 cells. Closely related compounds 12 and 17j showed no detectable activity, indicating a narrow structure-activity relationship. Exploratory single-concentration kinase profiling at 20 μM showed strong inhibition of several transcription-associated CDK/cyclin complexes (CDK13/CycK, CDK12/CycK, CDK9/CycT1, CDK19/CycC, and CDK8/CycC) and selected receptor tyrosine kinases (KDR/VEGFR2, RET, EPHA1, and FLT3). Compound 17k also suppressed colony formation and wound closure, induced apoptosis, and caused S-phase accumulation in HepG2 cells. These findings identify 17k as a nucleoside analogue with unanticipated antiproliferative activity and suggest that kinase modulation may contribute to its cellular effects. - Source: PubMed
Publication date: 2026/08/14
Wang SongYang JingYang XinyueHuang HaoZou HaiyangZhang YuZhang XushanLuo CongcongZhao BingLiu Feng-WuHerdewijn Piet - Cervical cancer represents the second most prevalent malignancy among women in India and is etiologically linked to persistent infection with high-risk human papillomavirus (HPV) strains. Mesua ferrea Linn, a medicinal tree species distributed across the Eastern Himalayan region, Eastern Indian states, and the Western Ghats, has demonstrated anticancer potential in several preclinical investigations; however, its mechanistic basis in cervical cancer remains insufficiently elucidated. In this study, a network pharmacology-based workflow was employed to identify the phytochemicals of Mesua ferrea, predict key targets, analyse protein-protein interactions and construct a compound-target pathway network along with network enrichment analysis. ADMET analysis, molecular docking, and molecular dynamics simulation were used to assess the stability of key compounds relative to potential targets. 16 phytochemicals, based on drug-likeness criteria, were identified, yielding 60 common targets, including AKT1, KDR, PIK3CA, MTOR, and EGFR, which are involved in Ras, PI3K-Akt, Jak-Stat, and HPV-associated pathways. Molecular docking and molecular dynamics simulations verified the stable binding of key phytochemicals to core cervical cancer-associated proteins. Collectively, these findings indicate that Mesua ferrea Linn exerts multi-target, multi-pathway regulatory effects in cervical cancer, supporting its potential as a source of phytotherapeutic agents. The study provides a mechanistic foundation for future in vitro and in vivo validation, contributing to the rational development of plant-derived interventions for cervical cancer management. - Source: PubMed
Publication date: 2026/08/14
Gaidhane Aryan ShyamMalvika A MVasava MaheshKevlani VijayPrajapati ApurvaPatel HiteshParmar ShivaliPrakash IlakkyaBhadra K SKhandelwal RiyaParmar ChintanRani ShreyaSreelakshmi O SMore Gayathri - Currently, the repair of bone defects faces multiple challenges, including insufficient angiogenesis and limited osteogenic differentiation capacity, which pose significant obstacles to treatment. In this study, a ternary composite scaffold composed of PCL-nHA-nMgO (PHM) was fabricated using 3D printing technology. After surface modification with a photothermal polydopamine (PDA) coating, a PHM@PDA composite scaffold was obtained. Metformin (Met) and PDA were loaded into GelMA hydrogels to produce GPM hydrogels. The GPM hydrogels were then packed into the PHM@PDA composite scaffolds, resulting in near-infrared region-I (NIR-I)-responsive PHM@PDA/GPM composite scaffolds. The outer GPM layer serves as a three-dimensional in vivo-like microenvironment, providing physical transport channels for cellular nutrient exchange. Upon stimulation by NIR-I, the scaffold enables the dynamic release of Mg2+ and Met, upregulates the expression of the VEGF and KDR, accelerates vascular network reconstruction, and creates a mild microenvironment conducive to cell proliferation. Furthermore, by activating the PI3K/AKT signaling pathway, it promotes the expression of osteogenesis-related factors (such as transcription factor Sp7, alkaline phosphatase, and osteocalcin), thereby accelerating the osteogenic differentiation process. In vivo animal experiments, micro-CT and tissue staining confirmed that, under near-infrared light (NIR-I) stimulation, this scaffold significantly increased bone mineral density, trabecular bone thickness, and trabecular bone count and demonstrated excellent angiogenic effects. In summary, this NIR-I-responsive composite scaffold can meet the dual requirements of reconstructing the vascular network and promoting osteogenic differentiation, enabling personalized precision therapy and offering a promising new treatment strategy for complex bone defects where vascular regeneration and osteogenic differentiation are challenging. - Source: PubMed
Publication date: 2026/08/17
Wang ShuaihangJi ZhonghaoShen DingLiu SiyuHao JingbinCheng QiJia BaoGuo LiangShang JieChen KaiHan Meng - Choroidal neovascularization (CNV) causes vision loss in neovascular age-related macular degeneration (nAMD) and pathologic myopia-related CNV (pmCNV). Despite shared clinical features, they respond differently to treatment. This study compared aqueous humor (AH) proteomic profiles of nAMD and pmCNV to identify biomarkers and mechanisms of CNV formation. - Source: PubMed
Zhao HanqingGao BenboDing NingZhang RuihengZhou WendaSong GuojiaoLi HeyanWu HaotianYang YuhangShao LeiDong LiWei Wenbin